MALAT1 is one of the highly cancer-relevant lncRNAs, expression of which is associated with progression of lung, pancreatic, prostate cancer and glioma and therefore, it has been proposed that MALAT1 could be a biomarker of several cancer types [3–5, 7]. Here, MALAT1 is linked to central nervous system cancer.